The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Population Screening in the Age of Genomic Medicine
Open accessAbstract
Newborns are now routinely screened for the presence of a number of inherited diseases. In these cases, early diagnosis allows treatment to be instituted before there are irreversible adverse consequences. However, as outlined in this installment in the Genomic Medicine series, clinical benefit can be derived from screening adults as well — not only for the genes associated with classic inherited conditions, such as cystic fibrosis and Tay–Sachs disease, but also for genes that are better considered risk factors for complex diseases, such as factor V Leiden and mutations associated with hereditary hemochromatosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS
Guthrie, R., & Susi, A. (1963) · Pediatrics · doi:10.1542/peds.32.3.338 · Cited by 2,219
Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia
Gaston, M. H., Verter, J. I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Vichinsky, E., Iyer, R., Lobel, J. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142501 · Cited by 1,162
World distribution of factor V Leiden
Rees, D. C., Cox, M., & Clegg, J. B. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91803-5 · Cited by 1,156
Vandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Rosendaal, F., Koster, T., Vandenbroucke, J., & Reitsma, P. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 1,004
Farrell, P. M., Kosorok, M. R., Rock, M. J., Laxova, A., Zeng, L., Lai, H.-C., Hoffman, G., Laessig, R. H., Splaingard, M. L., & the Wisconsin Cystic Fibrosis Neonatal Screening Study Group (2001) · Pediatrics · doi:10.1542/peds.107.1.1 · Cited by 837
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J., & Gelbart, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07447-0 · Cited by 823
Ridker, P. M. (1997) · JAMA · doi:10.1001/jama.1997.03540400055031 · Cited by 638
Mutations in the Connexin 26 Gene (GJB2) among Ashkenazi Jews with Nonsyndromic Recessive Deafness
Morell, R. J., Kim, H. J., Hood, L. J., Goforth, L., Friderici, K., Fisher, R., Van Camp, G., Berlin, C. I., Oddoux, C., Ostrer, H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392103 · Cited by 540
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., & Desnick, R. J. (2001) · Genetics in Medicine · doi:10.1097/00125817-200103000-00010 · Cited by 456
Ethical Issues With Genetic Testing in Pediatrics
Committee on Bioethics (2001) · Pediatrics · doi:10.1542/peds.107.6.1451 · Cited by 364
When can a risk factor be used as a worthwhile screening test?
Wald, N. J., Hackshaw, A. K., & Frost, C. D. (1999) · BMJ · doi:10.1136/bmj.319.7224.1562 · Cited by 341
Emmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., Stefano, V. D., Cumming, T., Arruda, V. R., Hillarp, A., & Reny, J. (2001) · PubMed · Cited by 325
Chace, D. H., Hillman, S. L., Van Hove, J. L. K., & Naylor, E. W. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.11.2106 · Cited by 280
Hereditary Hemochromatosis: Gene Discovery and Its Implications for Population-Based Screening
Burke, W., Thomson, E., Khoury, M. J., McDonnell, S. M., Press, N., Adams, P. C., Barton, J. C., Beutler, E., Brittenham, G., Buchanan, A., et al. (1998) · JAMA · doi:10.1001/jama.280.2.172 · Cited by 276
Self-citationWang, X. (2000) · JAMA · doi:10.1001/jama.284.14.1814 · Cited by 270
Serving the Family From Birth to the Medical Home
From the AAP Newborn Screening Task Force, E. G. V. (2000) · Pediatrics · doi:10.1542/peds.106.s2.389 · Cited by 244
Rosendaal, F., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Hillarp, A., Reny, J.-L., Emmerich, J., & the study group for pooled-analysis in venous thromboembolism (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616136 · Cited by 238
Andresen, B. S., Dobrowolski, S. F., O'Reilly, L., Muenzer, J., McCandless, S. E., Frazier, D. M., Udvari, S., Bross, P., Knudsen, I., Banas, R., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/320602 · Cited by 232
Prevalence of C282Y and H63D Mutations in the Hemochromatosis (HFE) Gene in the United States
Steinberg, K. K., Cogswell, M. E., Chang, J. C., Caudill, S. P., McQuillan, G. M., Bowman, B. A., Grummer-Strawn, L. M., Sampson, E. J., Khoury, M. J., & Gallagher, M. L. (2001) · JAMA · doi:10.1001/jama.285.17.2216 · Cited by 230
Self-citationPopulation-based genetic screening for reproductive counseling: the Tay-Sachs disease model
Kaback, M. M. (2000) · European Journal of Pediatrics · doi:10.1007/pl00014401 · Cited by 212
Factor V Leiden: should we screen oral contraceptive users and pregnant women?
Vandenbroucke, J. P., van der Meer, F. J. M., Helmerhorst, F. M., & Rosendaal, F. R. (1996) · BMJ · doi:10.1136/bmj.313.7065.1127 · Cited by 203
Burrow, G. N., & Dussault, J. H. (1980) · Raven Press eBooks · Cited by 190
American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing
Grody, W. W., Griffin, J. H., Taylor, A. K., Korf, B. R., & Heit, J. A. (2001) · Genetics in Medicine · doi:10.1097/00125817-200103000-00009 · Cited by 176
McCabe, E. R. B., Huang, S.-Z., Seltzer, W. K., & Law, M. L. (1987) · Human Genetics · doi:10.1007/bf00281061 · Cited by 168
Self-citationNaylor, E. W., & Chace, D. H. (1999) · Journal of Child Neurology · doi:10.1177/0883073899014001021 · Cited by 167
(1996) · PubMed Central · Cited by 165
Yang, Q., McDonnell, S. M., Khoury, M. J., Cono, J., & Parrish, R. G. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_2-199812011-00005 · Cited by 150
Self-citationJinks, D. C., Minter, M., Tarver, D. A., Vanderford, M., Hejtmancik, J. F., & McCabe, E. R. B. (1989) · Human Genetics · doi:10.1007/bf00283692 · Cited by 140
Self-citationMak, V., Zielenski, J., Tsui, L. C., Durie, P., Zini, A., Martin, S., Longley, T. B., & Jarvi, K. A. (1999) · JAMA · doi:10.1001/jama.281.23.2217 · Cited by 140
Gregg, R. G., Wilfond, B. S., Farrell, P. M., et al. (1993) · PubMed · Cited by 128
Genetic Testing for Cystic Fibrosis
Fibrosis, N. I. O. H. C. D. C. S. O. G. T. F. C. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.14.1529 · Cited by 126
Matsubara, Y., Narisawa, K., Ye-Qi, Y., Tada, K., Ikeda, H., Danks, D. M., Green, A., & McCabe, E. R. B. (1991) · The Lancet · doi:10.1016/0140-6736(91)91110-g · Cited by 112
Self-citationRaman, V. T., Clary, R. A., Siegrist, K. L., Zehnbauer, B. A., & Chatila, T. A. (2002) · PEDIATRICS · doi:10.1542/peds.109.1.e13 · Cited by 98
Contribution of different HFE genotypes to iron overload disease: a pooled analysis
Burke, W., Imperatore, G., McDonnell, S. M., Baron, R. C., & Khoury, M. J. (2000) · Genetics in Medicine · doi:10.1097/00125817-200009000-00001 · Cited by 85
Self-citationApplication of Population Screening Principles to Genetic Screening for Adult-Onset Conditions
Burke, W., Coughlin, S. S., Lee, N. C., Weed, D. L., & Khoury, M. J. (2001) · Genetic Testing · doi:10.1089/10906570152742245 · Cited by 72
Self-citationNewborn screening: rationale for a comprehensive, fully integrated public health system
McCabe, L. L., Therrell, B. L., & McCabe, E. R. B. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00196-8 · Cited by 61
Self-citation“Prevention” and the Goals of Genetic Medicine
Juengst, E. T. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.12-1595 · Cited by 57
Appraising organised screening programmes for testing for genetic susceptibility to cancer
Goel, V. (2001) · BMJ · doi:10.1136/bmj.322.7295.1174 · Cited by 48
Molecular Genetic Testing in Pediatric Practice: A Subject Review
American Academy of Pediatrics. Committee on Genetics (2000) · PEDIATRICS · doi:10.1542/peds.106.6.1494 · Cited by 44
EASL International Consensus Conference on Haemochromatosis
(2000) · Journal of Hepatology · doi:10.1016/s0168-8278(01)80875-8 · Cited by 44
Cystic fibrosis population carrier screening: Here at last—Are we ready?
Grody, W. W., & Desnick, R. J. (2001) · Genetics in Medicine · doi:10.1097/00125817-200103000-00001 · Cited by 43
Screening for hemochromatosis:
Cogswell, M. E., Burke, W., McDonnell, S. M., & Franks, A. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00141-x · Cited by 38
COMMITTEE ON GENETICS (1989) · PEDIATRICS · doi:10.1542/peds.83.3.449 · Cited by 34
Screening for cystic fibrosis: Feasibility of molecular genetic analysis of dried blood specimens
Seltzer, W. K., Accurso, F. J., Fall, M. Z., VanRiper, A. J., Descartes, M. D., Huang, Y. L., & McCabe, E. R. B. (1991) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(91)90055-p · Cited by 28
Self-citationNeonatal screening for cystic fibrosis: present and future
Wilcken, B. M., & Travert, G. (1999) · Acta Paediatrica · doi:10.1080/080352599750029330 · Cited by 26
Efficacy of a targeted genetic screening program for adolescents.
(1996) · PubMed Central · Cited by 18
Savage-Brown, A., GWINN, M. L., Cogswell, M. E., & Khoury, M. J. (2001) · Genetics in Medicine · doi:10.1097/00125817-200103000-00004 · Cited by 17
Self-citation
Cited by
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Andermann, A. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.050112 · Cited by 903
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns
Chace, D. H., Kalas, T. A., & Naylor, E. W. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.022178 · Cited by 621
Disclosure of APOE Genotype for Risk of Alzheimer's Disease
Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., Eckert, S. L., Butson, M., Sadovnick, A. D., Quaid, K. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809578 · Cited by 554
Metadata
- Authors
- Khoury, M. J., McCabe, L. L., & McCabe, E. R. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-01-02
- Volume
- 348
- Issue
- 1
- Pages
- 50-58
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2056297572
- Cited by
- 456
- References
- 49
- FWCI
- 24.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.